CXCL12 and type 2 diabetes mellitus: In contrast to the positive effects exerted by Saxagliptin + SDF-1α on T2D PACs, Saxagliptin +/- SDF-1α did not affect function of healthy control PACs when evaluated in the entire population, but differentially affected function of CD14+ monocytic versus CD14- lymphocytic cells.